Dipak Chetia

Dipak Chetia

Auto-generated profile, based on publicly available information

Dipak Chetia

Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
IOIsmail M.M. Othman
Ismail M.M. Othman
MMMahmoud H. Mahross
Mahmoud H. Mahross
MGMohamed A.M. Gad-Elkareem
Mohamed A.M. Gad-Elkareem
MRMithun Rudrapal
Mithun Rudrapal
NGNeelutpal Gogoi
Neelutpal Gogoi
AKAdel Kadri
Adel Kadri


2 February 2022 in ChemistrySelect
Verified
Journal Article
Open access
PDF file
JEJAMES ANAYOCHUKWU EZUGWU
JAMES ANAYOCHUKWU EZUGWU
UOUchechukwu Chris Okoro
Uchechukwu Chris Okoro
MEMercy. A. Ezeokonkwo
Mercy. A. Ezeokonkwo
KHKurma. S. Hariprasad
Kurma. S. Hariprasad
MRMithun Rudrapal
Mithun Rudrapal
OEOgechi. C. Ekoh
Ogechi. C. Ekoh
A new series of novel dipeptide sulfonamide analogues were designed, synthesized, and screened for their in silico studies and in vivo antimalarial activities. The synthesized compounds (50 mg/Kg) showed significant activity against P. berghei (NK65) with % inhibition values in (5.9 to 64.7 %) range in when compared with reference drug, artemisinin (66.7 %) in a four day suppressive assay. The in silico studies predicted favorable binding affinity of compounds with target protein residues with high dock score against P. falciparum falcipain 2 (FP‐2) and falcipain 3 (FP‐3) proteins in comparison with the reference ligands. The synthesized compounds showed druggable properties, and the predicted (absorption, distribution, metabolism, excretion and toxicities (ADMET) properties were within the acceptable limits. Molecular dynamics simulation study of the most active compound, 8 e was performed in order to further validate the stability of the protein‐ligand complex and the protein‐ligand interactions.

1 January 2016 in Asian Journal of Chemistry
Verified
Journal Article
Open access
DSDipshikha Sharma
Dipshikha Sharma
DCDipak Chetia
Dipak Chetia
Mithun RudrapalMithun Rudrapal
Mithun Rudrapal

9 October 2021 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
JZJames H. Zothantluanga
James H. Zothantluanga
NGNeelutpal Gogoi
Neelutpal Gogoi
ASAnshul Shakya
Anshul Shakya
DCDipak Chetia
Dipak Chetia
HLH Lalthanzara
H Lalthanzara
Background: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in 2019 and is still an on-going pandemic. SARS-CoV-2 uses a human protease called furin to aid in cellular entry and its main protease (Mpro) to achieve viral replication. By targeting these proteins, scientists are trying to identify phytoconstituents of medicinal plants as potential therapeutics for COVID-19. Therefore, our study was aimed to identify promising leads as potential inhibitors of SARS-CoV-2 Mproand furin using the phytocompounds reported to be isolated fromAcacia pennata(L.) Willd.Results: A total of 29 phytocompounds were reported to be isolated fromA. pennata. Molecular docking simulation studies revealed 9 phytocompounds as having the top 5 binding affinities towards SARS-CoV-2 Mproand furin. Among these phytocompounds, quercetin-3-O-α-L-rhamnopyranoside (C_18), kaempferol 3-O-α-L-rhamnopyranosyl-(1 → 4)-β-D-glucopyranoside (C_4), and isovitexin (C_5) have the highest drug score. However, C_18 and C_4 were not selected for further studies due to bioavailability issues and low synthetic accessibility. Based on binding affinity, molecular properties, drug-likeness, toxicity parameters, ligand interactions, bioavailability, synthetic accessibility, structure–activity relationship, and comparative analysis of our experimental findings with other studies, C_5 was identified as the most promising phytocompound. C_5 interacted with the active site residues of SARS-CoV-2 Mpro(GLU166, ARG188, GLN189) and furin (ASN295, ARG298, HIS364, THR365). Many phytocompounds that interacted with these amino acid residues were reported by other studies as potential inhibitors of SARS-CoV-2 Mproand furin. The oxygen atom at position 18, the –OH group at position 19, and the 6-C-glucoside were identified as the pharmacophores in isovitexin (also known as apigenin-6-C-glucoside). Other in-silico studies reported apigenin as a potential inhibitor of SARS-CoV-2 Mproand apigenin-o-7-glucuronide was reported to show stable conformation during MD simulations with SARS-CoV-2 Mpro.Conclusion: The present study found isovitexin as the most promising phytocompound to potentially inhibit the cellular entry and viral replication of SARS-CoV-2. We also conclude that compounds having oxygen atom at position 18 (C-ring), –OH group at position 19 (A-ring), and 6-C-glucoside attached to the A-ring at position 3 on a C6–C3–C6flavonoid scaffold could offer the best alternative to develop new leads against SARS-CoV-2.

8 February 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MSMalita Sarma
Malita Sarma
Mohnad AbdallaMohnad Abdalla
Mohnad Abdalla
JZJames H. Zothantluanga
James H. Zothantluanga
FTFelwa Abdullah Thagfan
Felwa Abdullah Thagfan
Abd. Kakhar UmarAbd. Kakhar Umar
Abd. Kakhar Umar
SASamia T. Al-Shouli
Samia T. Al-Shouli
Knipholone is an antiplasmodial phytocompound obtained from the roots of Kniphofia foliosa. Despite several available studies, the molecular drug targets of knipholone in P. falciparum remained unknown. Nowadays, in silico techniques are widely used to study the molecular interactions between compounds and proteins as they provide results quickly with high precision and accuracy. In this study, we aim to identify the potential molecular drug targets of knipholone in P. falciparum. We selected 10 proteins of P. falciparum with unique metabolic functions and we found that knipholone showed better binding affinity than the native ligands of 6 proteins. Out of the 6 proteins, knipholone showed better enzyme inhibitory potential than the native ligands of 4 proteins. We carried out a 100 ns MD simulations for knipholone and the native ligands of four proteins and this was followed by binding free energy calculations. In each step, the performance of knipholone was compared to the native ligands of the proteins. Knipholone outperformed the native ligand of Glutathione-S-Transferase (1OKT) at crucial computational studies as evidence from the lower protein–ligand root mean square deviation value, protein root mean square fluctuation value, and protein–ligand binding free energies. The ligand properties of knipholone provide additional evidence for its stability and it maintains adequate protein–ligand contacts during the entire simulation. The density functional theory study also supported the stability of knipholone at the active binding site of 1OKT. From the studied proteins, we conclude that Glutathione-S-Transferase is the most favorable drug target for knipholone in P. falciparum. Communicated by Ramaswamy H. Sarma